Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2018
Price : $35 *
At a glance
- Drugs Carbetocin (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 21 Jun 2018 According to the Levo Therapeutics media release, results of this study has been published in the JCI Insight.
- 21 Jun 2018 Results presented in the Levo Therapeutics media release.
- 19 Aug 2014 Status changed from recruiting to completed as reported by the ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History